Brent Ahrens

General Partner

Nandu Anilal

Investor

John Balen

General Partner

Joydeep Bhattacharyya

General Partner

Stephen Bloch

General Partner

Laura Chau

General Partner - East Coast

Colleen Cuffaro

Partner

Brendan Dickinson

General Partner

Peter Farina

Investor

Rayfe Gaspar-Asaoka

Partner

Julie Grant

General Partner

Stephen Green

Venture Partner

Wende Hutton

General Partner

Maha Ibrahim

General Partner

Deepak Kamra

General Partner

Nina Kjellson

General Partner

Ehud Levy

Co-Founder and General Partner, Canaan Partners Israel

Jared Newman

Investor

John Pacifico

General Partner

Julie Papanek

Partner

Hootan Rashidifard

Principal

Guy Russo

General Partner

Uwe Schoenbeck

Venture Partner

Tim Shannon

General Partner

Hrach Simonian

General Partner

Dana Warren

Venture Partner, East Coast

Bob Williams

Venture Partner

Eric Young

Partner

Mark Mangiola

Venture Partner

790 past transactions

Cynomi

Series B in 2025
Cynomi is a London-based company founded in 2021 that specializes in providing scalable virtual Chief Information Security Officer (vCISO) services through its AI-powered platform. The platform enables managed security service providers (MSSPs) and consulting firms to deliver comprehensive vCISO services without the need to expand their current resources. Cynomi's multi-tenant architecture automates the generation of essential vCISO deliverables, including risk and compliance assessments, customized security policies, actionable remediation plans, and task management tools. It conducts a thorough analysis of a company's cybersecurity posture, producing detailed and prioritized remediation strategies that are continuously updated. This approach facilitates optimal security and regulatory compliance for organizations, ensuring they remain protected in an evolving cyber landscape.

ThirtyFiveBio

Venture Round in 2025
ThirtyFiveBio is a biotechnology company developing novel genetically and pharmacologically validated protein modulators for treating severe gastrointestinal diseases.

AttoTude

Series B in 2025
AttoTude is a technology company specializing in the development of advanced interconnect solutions for AI and hyperscale data centers. It aims to surpass the limitations of existing data networking systems by creating innovative technology that significantly boosts bandwidth, enhances reliability, and reduces power consumption and costs.

Page

Seed Round in 2025
Page, an AI-powered external relations platform that provides real-time insights to help enterprises navigate government policies, media, and regulations.

Vivace Therapeutics

Series D in 2025
Founded in 2014, Vivace Therapeutics is a biotechnology company based in the San Francisco Bay Area. It focuses on discovering and developing cancer therapeutics by targeting novel pathways, with a particular emphasis on the Hippo pathway which controls tissue regeneration and organ size.

Heymilo

Seed Round in 2025
Heymilo is a technology company that specializes in developing generative AI-powered voice agent platforms. Their primary product is a voice-based screening tool designed to streamline the hiring process for businesses. The platform conducts dynamic two-way conversations with job candidates, assessing their skills, communication abilities, and cultural fit. This enables clients to save time, reduce unconscious bias, and make more informed hiring decisions.

Validated

Seed Round in 2025
Validated is a full-stack marketing solution provider. It assists clients with product-specific ad campaigns, from design and launch to scaling and iteration, ensuring continuous user acquisition through performance ads.

Neofin

Seed Round in 2025
Neofin develops AI-powered software for B2B payments workflows. It automates and streamlines financial processes, transforming how companies manage accounts receivable and billing. The platform offers multiple payment methods, reduced transactional fees, automated personalized billing, and real-time reconciliation.

Wise Layer

Seed Round in 2025
WiseLayer makes AI-powered digital workers for finance and accounting teams. It's AI digital workforce includes: - Angela, the AI agent for Accruals & Rev Rec (hire her at www.accruals.ai) - Dennis, the AI agent for Discrepancies & Financial Anomalies (hire him at www.discrepancies.ai) - … with the 4 newest AI agents eachspecializing in the following tasks: (1) bank reconciliations, (2) fixed asset depreciation & amortization, (3) lease accounting, and (4) prepaid expenses.

WiseLayer

Seed Round in 2025
WiseLayer is a company that creates AI-powered digital workers specifically designed for finance and accounting teams. The company offers a suite of specialized AI agents, including Angela, who focuses on accruals and revenue recognition, and Dennis, who addresses discrepancies and financial anomalies. In total, WiseLayer provides six AI agents that assist with various financial tasks such as bank reconciliations, fixed asset depreciation and amortization, lease accounting, and prepaid expenses. Additionally, WiseLayer develops an early warning system that employs artificial intelligence and analytics to help companies identify and address potential financial issues. This system includes pre-built tools that notify clients of known and emerging problems, enabling them to resolve issues swiftly through automation and reduce operational stress.

Enterpret

Series A in 2024
Enterpret is a company that specializes in customer feedback analytics, focusing on enhancing product development and customer insights. Its platform centralizes customer feedback from various channels, allowing businesses to collect and analyze this information efficiently. By leveraging advanced technologies in API design, analytics user interface and experience, and natural language processing, Enterpret helps organizations identify emerging trends and anomalies in customer feedback. This enables sales teams to transform unstructured feedback into actionable intelligence, facilitating a deeper understanding of customer needs and driving business growth.

Nivoda

Series C in 2024
Founded in 2017, Nivoda operates a B2B online marketplace for buying and selling diamonds and jewelry. It simplifies global trade by offering an all-in-one solution for partners, ensuring reliable sourcing and competitive pricing.

Glooko

Series F in 2024
Glooko develops a remote patient-monitoring platform for individuals with diabetes. It integrates with diabetes devices, fitness wearables, and activity trackers to capture data and provide reports, aiming to drive behavior change and improve health outcomes. The platform facilitates communication between patients and healthcare providers, enhancing care. Glooko is available on Android and iOS.

Safire Technology Group

Seed Round in 2024
Safire Technology Group specializes in the development of lithium-ion electrolyte additive technology aimed at enhancing battery safety. Their innovative technology prevents explosions and fires by facilitating an instantaneous transformation from liquid to solid upon mechanical impact, providing an additional layer of protection. This advancement not only enhances the safety of batteries but also imparts ballistic protection, making electric applications safer and more reliable. The company's solutions are designed to deliver cost-effective and higher-performing outcomes for clients in the electric applications sector.

AttoTude

Series A in 2024
AttoTude is a technology company specializing in the development of advanced interconnect solutions for AI and hyperscale data centers. It aims to surpass the limitations of existing data networking systems by creating innovative technology that significantly boosts bandwidth, enhances reliability, and reduces power consumption and costs.

Halda Therapeutics

Series B in 2024
Halda Therapeutics is a research-stage drug discovery company dedicated to developing next-generation precision medicine. The company employs a unique therapeutic modality that serves as a platform for addressing various disease states. By focusing on the discovery of novel therapies that modify disease-causing pathways, Halda Therapeutics aims to enable healthcare providers to offer more targeted treatments for their patients. Through its innovative approach, the company seeks to advance the field of precision medicine and improve patient outcomes.

Autobahn Therapeutics

Series C in 2024
Autobahn Therapeutics develops brain-targeting, small molecule therapies for central nervous system disorders. Its lead program ABX-002 is a thyroid hormone receptor beta agonist being developed as an adjunctive treatment for mood disorders, including major depressive disorder and bipolar depression. The company emphasizes precision tuning of CNS exposure, validated clinical and biologic targets, and biomarker-guided development across neuropsychiatry, neurodegeneration, and neuroinflammation to address high unmet medical needs and improve patient outcomes.

Catalym

Series D in 2024
Catalym GmbH, established in Munich, Germany in 2016, is a biotechnology company dedicated to developing innovative immunotherapies for cancer patients. The company focuses on neutralizing GDF-15, a central regulator of the immune system in the tumor microenvironment, aiming to demonstrate clinical proof-of-concept across multiple solid tumor indications with its lead program CTL-002. Catalym's mission is to transform cancer patients' lives by engaging their own immune systems and improving treatment options.

Nagish

Series A in 2024
Nagish develops an AI-driven communication platform designed to enhance accessibility for individuals who are deaf or hard of hearing. The platform facilitates real-time speech-to-text and text-to-speech conversion, enabling users to communicate via phone using text instead of voice.

Reibus

Venture Round in 2024
Reibus is an online marketplace designed for the buying and selling of metals, specifically targeting industrial markets. The company connects businesses with a network of metal suppliers, facilitating seamless transactions and logistics for metal transportation. Its platform includes features such as anonymous buying, real-time leads for sellers, and transparent shipping options. By providing a proprietary search tool and a streamlined materials listing process, Reibus aims to enhance price performance, minimize time to market, and expand market reach, ultimately reducing sales and marketing-related expenses for its users.

Greywolf Therapeutics

Series B in 2024
Grey Wolf Therapeutics is a biotechnology company based in Oxford, United Kingdom, focused on developing innovative immunotherapies for oncology. Founded in 2017, the company aims to enhance the visibility of non-responsive tumors to the immune system by directly modifying tumor cells. Its approach involves targeting endoplasmic reticulum aminopeptidases (ERAP) 1 and 2 within the antigen presentation pathway, which increases the neoantigen repertoire on tumor cells. This strategy is designed to improve the effectiveness of immunotherapy in treating cancer. Grey Wolf collaborates with leading academic and commercial partners to advance its drug discovery initiatives and deliver clinical candidates against well-validated targets in the field of immuno-oncology.

Truveris

Series E in 2024
Truveris is a health information technology company based in New York that focuses on bringing transparency to the prescription drug ecosystem. Founded in 2009, Truveris develops management tools for sponsors and payers of claims under prescription benefit plans. Its platform offers data-driven insights to help customers, including patients, employers, retailers, pharmacy benefits stakeholders, and manufacturers, manage rising costs and market access challenges effectively. The company's solutions include RxChoice, TruBid, and RxDash, which serve various entities in the pharmacy value chain.

Nivoda

Series B in 2024
Founded in 2017, Nivoda operates a B2B online marketplace for buying and selling diamonds and jewelry. It simplifies global trade by offering an all-in-one solution for partners, ensuring reliable sourcing and competitive pricing.

Quantum Circuits

Venture Round in 2024
Founded in 2015 by Dr. Robert Schoelkopf, Quantum Circuits develops and manufactures quantum computers based on superconducting devices. The company focuses on creating full-stack quantum computers designed for efficient scaling, with a pioneering approach to error detection and correction.

Qlaris Bio

Series B in 2024
Qlaris Bio is a clinical-stage biotechnology company based in Wellesley, Massachusetts, founded in 2017. The company specializes in developing innovative therapies for serious and debilitating ophthalmic diseases, with a focus on addressing episcleral venous pressure (EVP), a significant component of intraocular pressure (IOP). Qlaris Bio's lead therapy, QLS-101, aims to reduce IOP, thereby mitigating the risk of blindness in conditions such as Primary Open Angle Glaucoma and Normal Tension Glaucoma. The company also targets other high unmet need conditions related to disturbances in intraocular pressure, including a progressive pediatric rare disease with limited effective therapies.

Pathios Therapeutics

Series B in 2024
Pathios Therapeutics is an early-stage biotech company based in Oxford, United Kingdom, focused on developing therapies for autoimmune diseases and cancer. Founded in 2017, the company specializes in creating small molecule inhibitors that target the pH-sensing G protein-coupled receptor GPR65. These inhibitors are designed to counteract the immunosuppressive effects of immune cells, such as tumor-associated macrophages, which are influenced by the acidic environment often found in tumors. By leveraging a deep scientific approach and human genetic insights, Pathios Therapeutics aims to generate novel therapeutics for advanced solid tumors and other unmet medical needs.

Cynomi

Series A in 2024
Cynomi is a London-based company founded in 2021 that specializes in providing scalable virtual Chief Information Security Officer (vCISO) services through its AI-powered platform. The platform enables managed security service providers (MSSPs) and consulting firms to deliver comprehensive vCISO services without the need to expand their current resources. Cynomi's multi-tenant architecture automates the generation of essential vCISO deliverables, including risk and compliance assessments, customized security policies, actionable remediation plans, and task management tools. It conducts a thorough analysis of a company's cybersecurity posture, producing detailed and prioritized remediation strategies that are continuously updated. This approach facilitates optimal security and regulatory compliance for organizations, ensuring they remain protected in an evolving cyber landscape.

Alterome Therapeutics

Series B in 2024
Alterome Therapeutics is a precision oncology biotechnology company focused on developing alteration-specific therapeutics to target high-value, validated oncogenic drivers. It employs structure-guided drug discovery and advanced computational chemistry to create small-molecule therapies that selectively address oncogenic alterations, with the aim of improving patient outcomes in cancer.

Binarly

Seed Round in 2024
Binarly is a global company focused on firmware and software supply chain security, established in 2021 and headquartered in Los Angeles, California. The company offers the Binarly Transparency Platform, an AI-powered solution designed for device manufacturers, original equipment manufacturers, independent software vendors, and product security teams. This platform enables users to identify both known and unknown vulnerabilities, misconfigurations, and potential signs of malicious code within their firmware. By employing advanced machine learning and code analysis techniques, Binarly's platform provides in-depth introspection of firmware to detect threats that may arise below the operating system. The company’s validated remediation playbooks assist clients in significantly reducing the cost and time associated with addressing security exposures, ultimately aiming to protect businesses, critical infrastructure, and consumers globally.

Lily AI

Series B in 2024
Lily AI is an innovative e-commerce product discovery platform based in Mountain View, California, that focuses on enhancing the sales performance of brands and retailers. The company specializes in integrating customer-centric product attributes into various facets of the e-commerce ecosystem, including site search engines and recommendation systems. By aligning brand messaging with customer intent, Lily AI improves on-site search, personalized product discovery, and demand prediction. This approach enables retailers, particularly in the fashion, home, and beauty sectors, to achieve significant increases in traffic, conversion rates, revenue, and brand loyalty.

Nocion Therapeutics

Series B in 2024
Nocion Therapeutics is a biopharmaceutical company developing novel therapies called 'nocions' that selectively target actively firing nociceptors to provide relief for serious conditions such as cough, itch, pain, and inflammation.

Heymilo

Seed Round in 2024
Heymilo is a technology company that specializes in developing generative AI-powered voice agent platforms. Their primary product is a voice-based screening tool designed to streamline the hiring process for businesses. The platform conducts dynamic two-way conversations with job candidates, assessing their skills, communication abilities, and cultural fit. This enables clients to save time, reduce unconscious bias, and make more informed hiring decisions.

Anzenna

Seed Round in 2024
Anzenna is a security risk management company that specializes in mitigating insider threats. Its agentless platform employs artificial intelligence to calculate a security risk score for each employee and team, empowering organizations to proactively identify and address potential security breaches caused by insiders, which account for 68% of all security breaches.

JOOR

Venture Round in 2023
JOOR operates a digital wholesale platform that connects fashion brands and retailers worldwide. The system replaces manual ordering with automated B2B order management, payment processing, and virtual showrooms, enabling faster transactions and reduced errors. It supplies data analytics to help users track performance, cut costs, and enhance customer experience. Through a curated network of global partners, the platform supports brands and buyers in building strategic relationships and scaling operations across markets.

AgomAb Therapeutics

Series C in 2023
AgomAb Therapeutics N.V., based in Gent, Belgium, specializes in the development of molecular therapies aimed at regenerating damaged tissues. The company focuses on creating agonistic monoclonal antibodies, known as agomAbs, which are designed to stimulate molecular and cellular repair mechanisms. These therapies have the potential to restore organ function in patients suffering from fibrotic, inflammatory, autoimmune, and degenerative diseases. AgomAb targets biologically validated pathways, including Transforming Growth Factor β and Hepatocyte Growth Factor, while employing specialized capabilities in organ-specific small molecules and high-affinity antibodies. The company boasts a diversified clinical pipeline addressing various fibrotic conditions and possesses comprehensive research and development expertise, alongside a strong track record in business development.

Acesion Pharma

Series B in 2023
Founded in 2011, Acesion Pharma is a Danish biotech company dedicated to developing safe and tolerable treatments for atrial fibrillation (AF), the most common cardiac arrhythmia. The company focuses on inhibiting specific ion channels in heart cells to regulate the heart's rhythm and prevent AF recurrence.

Diligent Robotics

Venture Round in 2023
Diligent Robotics Inc. is a company that specializes in the development and manufacturing of hospital service robots. Founded in 2017 and headquartered in Austin, Texas, the company has created Moxi, a robotic assistant designed to support clinical and nursing staff with logistical tasks in hospital settings. Moxi is equipped with advanced mobile manipulation, social intelligence, and human-guided learning capabilities, allowing it to collaborate effectively with human teams. By automating routine logistical duties, Moxi enables healthcare providers to focus more on direct patient care, thereby enhancing patient satisfaction, service quality, and safety in healthcare environments. The company also develops artificial intelligence-based software suites that allow its robots to adapt to and thrive in dynamic, semi-structured environments.

Actio Biosciences

Series A in 2023
Actio Biosciences specializes in developing precision medicines tailored to homogeneous rare patient populations. Its pipeline focuses on creating new drugs designed to enhance clinical success rates and ultimately deliver treatments to all patients in need, including those with challenging-to-cure illnesses.

Atmosfy

Seed Round in 2023
Founded in 2021, Atmosfy is a San Francisco-based platform that helps users discover dining and nightlife options through video reviews. It covers restaurants, bars, cafes, and clubs nearby or afar, assisting users in making informed decisions based on their preferences.

Savvy

Series A in 2023
Savvy is a software development company that engages in cybersecurity.

Tomorrow.io

Series E in 2023
Tomorrow.io develops a SaaS weather intelligence platform that provides real-time, location-specific weather forecasts tailored to industries affected by weather. The platform helps organizations predict business impacts of weather, streamline communication, and optimize operations to improve efficiency and margins. It combines traditional meteorology data with signals from wireless networks, connected vehicles, satellites, street cameras, and other sources to deliver micro-forecast information. It serves clients across sectors worldwide, enabling countries, businesses, and individuals to manage weather-related challenges and improve decision-making. The company operates in North America, Latin America, Europe, and Asia.

Trebol

Seed Round in 2023
Trébol is a technology company that specializes in providing infrastructure for neobanks and fintech lenders, focusing on automating the onboarding process for financial institutions. The company's application programming platform facilitates efficient workflows and secure connections with various financial services, including payment, commerce, tax, and accounting systems. By standardizing data and distributing it through a universal application programming interface, Trébol's software eliminates manual tasks such as document data extraction and retrieval of official company records. This automation allows businesses to enhance their operational efficiency, reducing both time and costs associated with traditional processes.

OncoResponse

Venture Round in 2023
OncoResponse is an immuno‑oncology biotechnology company that uses a proprietary human antibody platform to discover novel targets and develop fully human monoclonal antibodies for cancer treatment. By interrogating the adaptive immune system of patients who respond exceptionally well to checkpoint inhibition, the company identifies genuine human antibodies against high‑value targets linked with immunosuppressive myeloid biology. Its pipeline aims to alleviate tumor‑microenvironment immunosuppression and enhance immune activation, converting cold tumors into hot ones and providing new therapeutic options for patients.

Antiva Biosciences

Series E in 2023
Antiva Biosciences, Inc. is a biopharmaceutical company based in South San Francisco, California, focused on developing antiviral therapies for human papillomavirus (HPV) infections. Established in 2012, the company aims to prevent cancer by treating precancerous lesions associated with HPV. Antiva's innovative approach includes localized therapeutics and small molecule antivirals that target HPV and other viral infections. The company is currently conducting clinical trials for high-grade anal intraepithelial neoplasias and high-grade cervical intraepithelial neoplasias. Through its medicinal chemistry platform, Antiva strives to enhance health outcomes for patients affected by HPV-related diseases and other viral infections.

Kepler Communications

Series C in 2023
Kepler Communications designs, develops, and operates satellite networks for global connectivity. It specializes in Low-Earth Orbit (LEO) satellites, PolarConnect for extreme environments, Global Data Service for large data transfers, and everywhereIOT for IoT devices. Serving industries such as maritime, natural resources, research, defense, and logistics.

Aer Therapeutics

Series A in 2023
Aer Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative treatments for respiratory diseases characterized by excess mucus and mucus plugs. Its primary focus lies in addressing significant unmet needs in conditions such as chronic obstructive pulmonary disease (COPD), cystic fibrosis, and asthma.

Assis

Seed Round in 2023
Assis goal is to empower business owners by helping them grow their companies through technology that gives customers an amazing experience each and every time they connect with them.

Relievant Medsystems

Venture Round in 2023
Relievant Medsystems, Inc. is a medical device company focused on developing innovative solutions for chronic axial low back pain. Founded in 2004 and headquartered in Minneapolis, Minnesota, with a development office in Sunnyvale, California, the company has created the Intracept System. This minimally invasive procedure specifically targets the basivertebral nerve, providing relief by blocking pain signal transmission. The Intracept System offers patients a low-risk therapy option aimed at alleviating chronic vertebrogenic low back pain.

Mantra Health

Series A in 2023
Mantra Health is a digital mental healthcare provider specializing in university students. It offers integrated telemental health programs, improving clinical outcomes and reducing wait times for universities of all sizes.

Greywolf Therapeutics

Series B in 2023
Grey Wolf Therapeutics is a biotechnology company based in Oxford, United Kingdom, focused on developing innovative immunotherapies for oncology. Founded in 2017, the company aims to enhance the visibility of non-responsive tumors to the immune system by directly modifying tumor cells. Its approach involves targeting endoplasmic reticulum aminopeptidases (ERAP) 1 and 2 within the antigen presentation pathway, which increases the neoantigen repertoire on tumor cells. This strategy is designed to improve the effectiveness of immunotherapy in treating cancer. Grey Wolf collaborates with leading academic and commercial partners to advance its drug discovery initiatives and deliver clinical candidates against well-validated targets in the field of immuno-oncology.

Komprise

Series D in 2023
Komprise, Inc. is a data management software company founded in 2014 and headquartered in Campbell, California. It specializes in intelligent data-aware management solutions that enable organizations to store, organize, and analyze both on-premise and cloud-based data. The company's platform allows users to easily analyze and mobilize file and object data across multiple cloud environments, providing flexibility without vendor lock-in. Komprise's software employs data growth analytics to identify and manage both frequently accessed (hot) and infrequently accessed (cold) data, ensuring that unstructured data is moved to appropriate secondary storage based on criteria such as age and usage. This comprehensive approach facilitates efficient data lifecycle management, including replication, archiving, and migration.

WiseLayer

Seed Round in 2023
WiseLayer is a company that creates AI-powered digital workers specifically designed for finance and accounting teams. The company offers a suite of specialized AI agents, including Angela, who focuses on accruals and revenue recognition, and Dennis, who addresses discrepancies and financial anomalies. In total, WiseLayer provides six AI agents that assist with various financial tasks such as bank reconciliations, fixed asset depreciation and amortization, lease accounting, and prepaid expenses. Additionally, WiseLayer develops an early warning system that employs artificial intelligence and analytics to help companies identify and address potential financial issues. This system includes pre-built tools that notify clients of known and emerging problems, enabling them to resolve issues swiftly through automation and reduce operational stress.

Paway

Pre Seed Round in 2022
Paway is a company founded by Jason Meltzer, the former CEO of Wag, aiming to enhance the pet care community for the next generation of pet owners, particularly Gen-Z and Millennials. The company offers a pet tracking application that provides real-time safety alerts and neighborhood tips to ensure the safety of pets during walks. Its platform allows users to create and share pet profiles with a network of caregivers, facilitating communication and sharing of experiences. Paway also includes pet care professionals in its community, providing them with software to help manage and grow their businesses. By connecting pet care professionals with pet parents, Paway addresses consumer demand while lowering the costs of pet care services and fostering loyalty among pet professionals. The platform collects valuable user data, including pet details and location, to further enhance its offerings and community engagement.

Normunity

Series A in 2022
Normunity is a biotechnology company that develops precision immuno‑oncology medicines, termed immune normalizers, designed to restore the body’s natural immune response against cancer. Leveraging a partnership with Dr. Lieping Chen’s laboratory at Yale School of Medicine, the company focuses on newly discovered mechanisms of immune disruption, such as the exclusion of T‑cells from immune‑sensitive tumors and other barriers to normal immune function. Its pipeline includes programs targeting these mechanisms to enable clinicians to treat cancer by reactivating the patient’s own immunity. Normunity operates from offices in Boston, Massachusetts, and West Haven, Connecticut.

Alkymi

Series A in 2022
Alkymi develops an AI-powered platform that automates the processing of unstructured investment data. Its solution transforms financial documents like capital calls and brokerage statements into standardized datasets, enabling financial services professionals to accelerate deal reviews, serve more clients, and respond swiftly to market changes.

PIN

Seed Round in 2022
PIN is a company that specializes in facilitating the connection between entrepreneurs and investors through a community fund platform. It provides essential services such as back office support, legal frameworks, and tax assistance to help organizations establish and manage investment vehicles. By enabling both accredited and unaccredited investors to participate, PIN creates opportunities for communities to raise capital. The company's focus is on empowering entrepreneurs and leaders to seek funding opportunities, network with other members, and effectively manage their investment portfolios.

PIN

Funding Round in 2022
PIN is a company that specializes in facilitating the connection between entrepreneurs and investors through a community fund platform. It provides essential services such as back office support, legal frameworks, and tax assistance to help organizations establish and manage investment vehicles. By enabling both accredited and unaccredited investors to participate, PIN creates opportunities for communities to raise capital. The company's focus is on empowering entrepreneurs and leaders to seek funding opportunities, network with other members, and effectively manage their investment portfolios.

Aceiss

Seed Round in 2022
Aceiss offers a compliance monitoring platform that enhances access security by providing real-time insights into user activity. It integrates with existing applications and security infrastructure to identify unusual behavior and protect privileged accounts, helping businesses anticipate potential security threats.

EMTECH

Seed Round in 2022
EMTECH is a fintech company that modernizes central banking infrastructure. It offers an API-First Platform connecting central banks with fintechs for embedded regulatory compliance and central bank digital currency, enabling financial inclusion and market resilience.

Contentsquare

Series F in 2022
ContentSquare is a digital experience insights optimization platform that helps businesses analyze customer behavior through vast amounts of anonymous web, mobile, and app interactions, adhering to data privacy regulations such as the EU GDPR and California CCPA. By integrating diverse data sets, including content, user experience, product offerings, pricing, acquisition channels, and technical performance, the platform generates insights and AI-driven recommendations to enhance digital performance throughout the customer journey. Its solutions enable clients to better understand user interactions, measure content effectiveness, and clarify consumer intentions, ultimately leading to increased revenue and engagement while reducing operational costs. ContentSquare serves over 700 enterprise clients, including notable brands like American Express, Best Buy, and LVMH.

Hank

Seed Round in 2022
Hank is a digital platform connecting adults aged 55 and above with others in their community through shared interests. It facilitates offline activities and friendships by curating group events such as pickleball, canasta, and skydiving.

Appsmith

Series B in 2022
Appsmith is a company that specializes in open-source low-code software aimed at facilitating the rapid development of custom internal applications. Founded in mid-2019, Appsmith's platform allows developers to create, deploy, and manage applications with a focus on enterprise-grade security and governance. The software simplifies the development of internal tools, streamlining operations, automating processes, and enabling seamless integration of various applications and data sources. With over 5 million downloads and a user base that includes more than 1,000 enterprises across over 100 countries, Appsmith has established itself as a significant player in the low-code application development space, empowering developers to enhance legacy applications and build efficient internal web apps.

WorkMotion

Series B in 2022
WorkMotion is a global HR platform founded in 2020 and headquartered in Berlin, Germany. The company specializes in facilitating the hiring and onboarding of employees internationally, allowing organizations to recruit and manage remote workers from various countries with ease. Its cloud-based workforce management platform streamlines the hiring process by enabling employers to consolidate global payroll accounting and manage freelancers without the need to establish legal entities in foreign markets. By providing a comprehensive solution for international employment, WorkMotion supports businesses in expanding their talent acquisition capabilities across borders.

Lily AI

Venture Round in 2022
Lily AI is an innovative e-commerce product discovery platform based in Mountain View, California, that focuses on enhancing the sales performance of brands and retailers. The company specializes in integrating customer-centric product attributes into various facets of the e-commerce ecosystem, including site search engines and recommendation systems. By aligning brand messaging with customer intent, Lily AI improves on-site search, personalized product discovery, and demand prediction. This approach enables retailers, particularly in the fashion, home, and beauty sectors, to achieve significant increases in traffic, conversion rates, revenue, and brand loyalty.

Marvin

Series A in 2022
Marvin is a B2B fintech company specializing in transforming trade credit management for industries selling to retail. By utilizing credit card receivables as collateral, Marvin offers an innovative alternative to traditional Trade Credit Insurance, providing simplicity, flexibility, and risk mitigation.

Dusty Robotics

Series B in 2022
Dusty Robotics, Inc. is a technology company that specializes in automated layout services for the construction industry. Founded in 2018 and headquartered in Mountain View, California, the company has developed the FieldPrinter, a robotic tool that translates digital building information modeling (BIM) designs into accurate, on-site layouts. By integrating BIM information directly onto construction-site floors, Dusty Robotics eliminates manual processes, thereby enhancing efficiency in the construction workflow. The company's innovative solutions serve a diverse clientele, including owners, general contractors, subcontractors, and builders, helping them to reduce labor and material waste and improve the overall design-build-operate lifecycle.

Theia

Seed Round in 2022
Theia is a pioneering personalized health service tailored specifically for mothers, offering a comprehensive platform that connects them with a network of vetted healthcare professionals. Designed to support women from preconception through early childhood, Theia provides both remote and in-person consultations, ensuring access to holistic care at every stage of motherhood. The platform utilizes data to deliver timely content and advice related to pregnancy, while also facilitating communication with a diverse team of specialists, including psychologists, doctors, and nurses. Theia's commitment to personalized care is underscored by its focus on understanding and respecting each woman's individual needs throughout her journey into motherhood.

Lev

Series B in 2022
Founded in 2019, Lev specializes in digitizing commercial real estate transactions via its technology platform. It offers financial services, including lending solutions and capital management.

RenoFi

Series A in 2022
RenoFi is a financial technology company that operates a renovation financing marketplace, connecting homeowners with local banks to facilitate renovation loans. By utilizing its technology platform, RenoFi enables lenders to provide loans based on the after renovation value of a home rather than its current market value, allowing homeowners to borrow larger amounts at lower interest rates. The platform not only offers competitive renovation loan options but also includes home valuation services, ensuring that homeowners have access to instant loan solutions to enhance the value of their properties.

BoostUp.ai

Series B in 2022
BoostUp.ai offers a sales intelligence platform that transforms unstructured data into actionable insights. Its solution analyzes risks at macro and micro levels, enhancing forecasting accuracy, efficiency, and predictability across the entire sales process. The company serves prominent clients such as Teradata, Degreed, and Iterable.

Hermeus

Series B in 2022
Hermeus Corporation, founded in 2018 and based in Atlanta, Georgia, is focused on developing hypersonic aircraft capable of flying at speeds exceeding Mach 5. These advanced jets significantly reduce travel times, allowing a flight from New York to London to take just 90 minutes instead of the typical seven hours. Hermeus aims to enhance the global transportation network by enabling businesses to operate efficiently without major changes to existing aviation infrastructure. The company's innovations not only decrease flight durations but also enhance safety for long-haul and business class air travel, facilitating improved connectivity between major global cities.

EMTECH

Seed Round in 2022
EMTECH is a fintech company that modernizes central banking infrastructure. It offers an API-First Platform connecting central banks with fintechs for embedded regulatory compliance and central bank digital currency, enabling financial inclusion and market resilience.

Rondo Therapeutics

Series A in 2022
Rondo Therapeutics is a biopharmaceutical company based in Hayward, California, specializing in the discovery and development of innovative bispecific antibodies aimed at activating the immune system to combat cancer. Founded in 2021, the company focuses on creating cancer immunotherapies specifically for solid tumor types that do not respond to existing immune checkpoint inhibitors. By addressing areas of unmet medical need, Rondo Therapeutics aims to advance novel therapeutic options for patients facing challenging cancer diagnoses.

Earnipay

Seed Round in 2022
Earnipay is a business payment software company that facilitates instant access to earned salaries for employees, allowing them to receive a portion of their daily earnings without altering existing payroll processes. By partnering with employers, Earnipay integrates with payroll systems to offer employees a seamless way to access their wages as needed. In addition to salary disbursement, the platform provides financial education and personal finance management tools aimed at enhancing employees' financial well-being. Through its services, Earnipay seeks to improve the overall financial health of the workforce, benefiting both employees and employers.

Instrumental

Series C in 2022
Instrumental, Inc. specializes in developing software solutions that enhance the efficiency of assembly lines, enabling them to operate autonomously while adapting to various parts and processes. Founded by former Apple engineers Anna-Katrina Shedletsky and Samuel Weiss, the company aims to reduce costs associated with scrap and rework by allowing manufacturers to identify and resolve issues on their assembly lines. Instrumental's technology has been deployed in multiple global assembly lines at leading manufacturers, helping to prevent delays in development schedules and start production at higher yields. In addition to its software offerings, Instrumental also provides services related to high-performance computing, data storage, and business continuity, catering to both commercial and government sectors. The firm is headquartered in Saint Paul, Minnesota, and has been operational since 1991.

Gemist

Seed Round in 2022
Gemist is a Los Angeles-based jewelry company established in 2018. It specializes in designing and manufacturing customizable rings and other accessories, with a focus on millennial consumers. Gemist's unique business model allows customers to design their pieces online, receive free replicas for trial at home before purchasing.

Mantra Health

Series A in 2022
Mantra Health is a digital mental healthcare provider specializing in university students. It offers integrated telemental health programs, improving clinical outcomes and reducing wait times for universities of all sizes.

Azibo

Series A in 2022
Founded in 2018, Azibo is a financial services platform dedicated to streamlining rental property management. It offers solutions for rent collection, banking, lending, and insurance, aiming to improve efficiency and reduce administrative burden for small real estate owners.

Treehouse

Seed Round in 2022
Treehouse is a venture-backed software-enabled home electrification startup focused on delivering turnkey EV charging solutions to EV buyers at the point of sale.

Taptap Send

Series B in 2021
Taptap Send is a mobile application that facilitates instant money transfers for immigrants sending funds back to Africa at low costs. Launched in the summer of 2018, the platform has successfully processed hundreds of millions of dollars and serves hundreds of thousands of customers. It operates in seven European countries and enables payments to various countries, including Ivory Coast, Senegal, Mali, Ghana, Guinea, Cameroon, Bangladesh, Kenya, Madagascar, Zambia, Vietnam, and the Democratic Republic of the Congo, with plans for further expansion. Taptap Send simplifies the remittance process by allowing users to transfer money directly to mobile money wallets using just a debit card, eliminating the need for physical deposits and saving time for its clients.

Apex.AI

Series B in 2021
Apex.AI develops software for autonomous mobility, offering a framework and tools that simplify the development of safe and secure autonomous driving applications. Its platform includes Apex.OS, which abstracts hardware, middleware, kernels, interfaces, and drivers into usable APIs, and Apex.Autonomy for safety-critical applications. It also offers MARV.Automotive, a data management platform that transfers vehicle data to the cloud, enables dynamic search-based analytics, analyzes partial logs, runs algorithms on real data, and provides graphical data introspection and team collaboration. Founded in 2017 and based in Palo Alto, California, Apex.AI builds on open-source software such as ROS and Eclipse iceoryx to provide building blocks for developers creating AI and safety-critical software for autonomous vehicles.

Edge Impulse

Series B in 2021
Edge Impulse is a software platform focused on simplifying the development of machine learning models optimized for edge devices, where data is collected. The platform streamlines the entire process, encompassing data acquisition, signal processing, machine learning training, model testing, and deployment. It enables developers to create intelligent applications by facilitating the collection of real sensor data and processing it from raw inputs to neural networks. Edge Impulse's technology supports a wide range of devices, allowing for efficient operation on various hardware from microcontrollers to GPUs. By enhancing the accessibility and efficiency of embedded machine learning applications, Edge Impulse aims to promote positive societal change through advanced technology.

Ottopay

Seed Round in 2021
Otto is an intelligent and automated debt management platform. We help the 8 in 10 Americans with debt save on interest, improve their credit score, and get debt-free faster — all done (you guessed it) automatically.

Sounding Board Labs

Series B in 2021
Founded in 2016, Sounding Board Labs develops a platform that provides personalized coaching for leaders and new managers. Its platform offers executive coaching, connects through phone, video, and chat, creates development plans, and provides surveys and reporting to track progress.

Reibus

Series B in 2021
Reibus is an online marketplace designed for the buying and selling of metals, specifically targeting industrial markets. The company connects businesses with a network of metal suppliers, facilitating seamless transactions and logistics for metal transportation. Its platform includes features such as anonymous buying, real-time leads for sellers, and transparent shipping options. By providing a proprietary search tool and a streamlined materials listing process, Reibus aims to enhance price performance, minimize time to market, and expand market reach, ultimately reducing sales and marketing-related expenses for its users.

Jina Ai

Series A in 2021
Jina AI is a Beijing-based company specializing in neural search solutions powered by artificial intelligence and deep learning, which was founded in 2020. The company offers a cloud-native search framework designed for enterprises and developers, facilitating the management and deployment of various data types. Jina AI's Search Foundation features innovative components such as Embeddings, Rerankers, and Small Language Models, enabling users to develop advanced generative AI and multimodal search applications. Its open-source approach allows for flexibility and scalability, empowering businesses to harness the full potential of their data efficiently.

nTopology

Series D in 2021
nTopology, Inc. is an engineering software company founded in 2013 and headquartered in New York, New York. The company specializes in developing design software and tools aimed at optimizing manufacturing processes. Its flagship platform, nTopology, empowers engineers to create lightweight and optimized parts that meet specific functional requirements. The software includes features such as Lightweighting, Architected Materials, Topology Optimization, Additive Manufacturing, and Design Analysis, facilitating the integration of geometry and simulation data into manufacturing-ready models. By streamlining workflows and enhancing team collaboration, nTopology serves a diverse range of industries, including aerospace and defense, medical, automotive, consumer products, and education.

Clutch

Series B in 2021
Clutch is a technology company revolutionizing car buying, selling, and ownership. It offers high-quality certified vehicles through a seamless online customer experience, with inventory browsing, purchase completion, and effortless home delivery. Clutch aims to provide customers with a delightful car-buying journey while positively impacting communities.

CompStak

Series C in 2021
CompStak, Inc., founded in 2011 and headquartered in New York, operates an online platform that provides a comprehensive database of commercial lease comparables. Utilizing a crowd-sourced model, CompStak facilitates the exchange of detailed lease information, which includes tenant names, addresses, rental rates, square footage, landlord concessions, broker identities, and other pertinent data. This information is critical for real estate investors, brokers, asset managers, and appraisers as they conduct valuations and analyses of commercial properties. CompStak's platform serves various stakeholders in the real estate market, enabling informed decision-making in significant investments and property comparisons. Additionally, CompStak has established a strategic partnership with Knowledge Cubed to enhance its data offerings, further solidifying its position in the industry.

Papa

Series D in 2021
Papa, Inc. operates an online platform designed to connect college students with senior citizens, facilitating various services to assist older adults in maintaining their independence and well-being. Founded in 2016 and based in Miami, Florida, the platform enables college and nursing students to provide companionship and assistance in areas such as transportation, house chores, technology lessons, grocery shopping, and caregiving. By connecting vetted companions with older adults, Papa aims to enhance social connections and support for seniors, allowing them to live securely and happily at home.

Antiva Biosciences

Series D in 2021
Antiva Biosciences, Inc. is a biopharmaceutical company based in South San Francisco, California, focused on developing antiviral therapies for human papillomavirus (HPV) infections. Established in 2012, the company aims to prevent cancer by treating precancerous lesions associated with HPV. Antiva's innovative approach includes localized therapeutics and small molecule antivirals that target HPV and other viral infections. The company is currently conducting clinical trials for high-grade anal intraepithelial neoplasias and high-grade cervical intraepithelial neoplasias. Through its medicinal chemistry platform, Antiva strives to enhance health outcomes for patients affected by HPV-related diseases and other viral infections.

Dragos

Series D in 2021
Dragos is an industrial cybersecurity company dedicated to protecting the world's critical infrastructure. Its platform offers visibility into industrial control systems (ICS) and operational technology (OT) networks, enabling early threat detection and mitigation.

Countable

Series A in 2021
Countable provides virtual community management for corporations, nonprofits, and political campaigns. It uses technology to communicate and strengthen human interconnectedness, delivering technology solutions that facilitate community engagement.

Appsmith

Series A in 2021
Appsmith is a company that specializes in open-source low-code software aimed at facilitating the rapid development of custom internal applications. Founded in mid-2019, Appsmith's platform allows developers to create, deploy, and manage applications with a focus on enterprise-grade security and governance. The software simplifies the development of internal tools, streamlining operations, automating processes, and enabling seamless integration of various applications and data sources. With over 5 million downloads and a user base that includes more than 1,000 enterprises across over 100 countries, Appsmith has established itself as a significant player in the low-code application development space, empowering developers to enhance legacy applications and build efficient internal web apps.

TAG

Seed Round in 2021
TAG is a mobile application that allows users to access an e-money account through a debit card. They provide a money transfer feature that helps to transfer money to any bank or wallet. They specialize in digital wallets and payment services.

Bzaar

Seed Round in 2021
Bzaar is an online B2B cross-border marketplace founded in 2020 and headquartered in San Francisco, California. The company specializes in connecting small businesses with a diverse range of products, including home improvements, fashion, cookware, and bakeware, primarily sourced from South and South-East Asia. Bzaar provides retailers access to niche and artisanal products from value-based brands that are often unavailable at traditional big-box retail chains. By facilitating cross-border wholesale transactions, Bzaar enhances buying transparency and predictability for small and medium enterprises, allowing them to effectively meet their inventory needs.

TrueFort

Series B in 2021
TrueFort specializes in real-time application and cloud workload protection. Founded in 2015, the company offers solutions such as application-first security, out-of-box analytics for applications, and bring-your-own-agent capabilities. Its flagship product, Fortress, employs advanced behavioral analysis and automation to enhance security across diverse environments.

Tropic

Series A in 2021
Tropic equips finance and procurement teams with tools to manage tech spending effectively. It combines unbiased market data with spend management features, helping users reduce costs, enhance efficiency, and maintain clear visibility over their expenditures.

Canopy

Series A in 2021
Canopy’s modern loan management and servicing platform helps Fintechs and brands service customer accounts through automations and APIs to help improve borrower repayment rates, increase net promoter scores, and decrease the cost of servicing for lending and credit card products.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.